BioCentury | Apr 19, 2019
Targets & Mechanisms

The next wave in neurodegeneration expands beyond neurons

...Alector Inc. (NASDAQ:ALEC) / AbbVie Inc. (NASDAQ:ABV) AL003 AD Ph I Complement Complement 6 (C6) Complement Pharma...
...glaucoma. At least two other companies are targeting downstream complement proteins: Alsonex Pty. Ltd. and Complement Pharma...
...this quarter testing ALS-205 in healthy volunteers, then plans to develop the antibody for ALS. Complement Pharma...
BioCentury | Jun 15, 2018
Company News

Alexion partners with Complement, divests non-core asset

...Pharmaceuticals Inc. (NASDAQ:ALXN) announced a pair of deals on June 11, including a deal with Complement Pharma...
...individual subsidiaries (see BioCentury, Sept. 15, 2017) . Alexion Pharmaceuticals Inc. (NASDAQ:ALXN), New Haven, Conn. Complement Pharma...
...Palo Alto, Calif. Business: Neurology Jennie Walters CP010 Cyclic pyranopterin monophosphate (cPMP) replacement therapy (ALXN1101) Alexion Pharmaceuticals Inc. BridgeBio Pharma LLC Complement Pharma Orphatec...
BioCentury | Jun 11, 2018
Company News

Alexion partners with Complement, divests non-core asset

...Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) announced a pair of deals on Monday, including a deal with Complement Pharma...
Items per page:
1 - 3 of 3
BioCentury | Apr 19, 2019
Targets & Mechanisms

The next wave in neurodegeneration expands beyond neurons

...Alector Inc. (NASDAQ:ALEC) / AbbVie Inc. (NASDAQ:ABV) AL003 AD Ph I Complement Complement 6 (C6) Complement Pharma...
...glaucoma. At least two other companies are targeting downstream complement proteins: Alsonex Pty. Ltd. and Complement Pharma...
...this quarter testing ALS-205 in healthy volunteers, then plans to develop the antibody for ALS. Complement Pharma...
BioCentury | Jun 15, 2018
Company News

Alexion partners with Complement, divests non-core asset

...Pharmaceuticals Inc. (NASDAQ:ALXN) announced a pair of deals on June 11, including a deal with Complement Pharma...
...individual subsidiaries (see BioCentury, Sept. 15, 2017) . Alexion Pharmaceuticals Inc. (NASDAQ:ALXN), New Haven, Conn. Complement Pharma...
...Palo Alto, Calif. Business: Neurology Jennie Walters CP010 Cyclic pyranopterin monophosphate (cPMP) replacement therapy (ALXN1101) Alexion Pharmaceuticals Inc. BridgeBio Pharma LLC Complement Pharma Orphatec...
BioCentury | Jun 11, 2018
Company News

Alexion partners with Complement, divests non-core asset

...Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) announced a pair of deals on Monday, including a deal with Complement Pharma...
Items per page:
1 - 3 of 3